CoLucid

Pharma

CoLucid in talks with partners for novel migraine treatment

Central nervous system drug development company CoLucid is currently in talks with potential partners who could take its investigational migraine headache treatment into late-stage clinical trials. The company offered no details on the prospective drug partners, but said it does now have the U.S. Food and Drug Administration’s go-ahead to proceed with phase 3 trials. […]